Business
Akadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance Program
Akadeum Life Sciences, the leader in buoyant cell separation, announces the establishment of the Akadeum CDMO Alliance™ and the first two members in the consortium. The exclusive Akadeum CDMO Alliance builds on the strong relationships Akadeum has built with leading CDMOs in the cell therapy space and seeks to be a bastion for innovation in reducing costs, time, and access to cell therapies while delivering best-in-class performance.
About this update from Charles River Laboratories International, Inc.
[{"type":"text","content":"Cell therapy manufacturers Charles River and ElevateBio are named as inaugural members","length":86,"tagName":"p","attribs":{}},{"type":"text","content":"ANN ARBOR, Mich., Dec. 9, 2025 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant cell separation, announces the establishment of the Akadeum CDMO Alliance™ and the first two members in the consortium. The exclusive Akadeum CDMO Alliance builds on the strong relationships Akadeum has built with leading CDMOs in the cell therapy space and seeks to be a bastion for innovation in reducing costs, time, and access to cell therapies while delivering best-in-class performance.","length":494,"tagName":"p"},{"type":"image","alt":"The Akadeum CDMO Alliance™ consisting of Bubble Certified™ companies Charles River and ElevateBio. These inaugural members receive early access to kits in development to be at the forefront of innovations in cell separation. Microbubbles are driving reduced costs and increased access with a significant ROI of up to 40% savings on cell therapy manufacturing workflow costs.","displaySize":"","headline":null,"caption":"The Akadeum CDMO Alliance™ consisting of Bubble Certified™ companies Charles River and ElevateBio. These inaugural members receive early access to kits in development to be at the forefront of innovations in cell separation. Microbubbles are driving reduced costs and increased access with a significant ROI of up to 40% savings on cell therapy manufacturing workflow costs.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/c5e0eac68a6e6dfb93c845e01e861a6a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/I7xwZrFIGrYrDLXcQUic4A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/c5e0eac68a6e6dfb93c845e01e861a6a","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2839621/Akadeum_Life_Sciences_Inc_Image.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Inaugural Members of the Akadeum CDMO Alliance: ElevateBio® and Charles River. Akadeum has collaborated with both CDMOs, establishing strong data sets demonstrating reduced impurities and high potency of T cells isolated with microbubbles via negative selection.","length":267,"tagName":"p"},{"type...
More updates from Charles River Laboratories International, Inc.